Key facts
- SIAMAF Healthcare’s last known valuation is $790K (Jul 2020).
- It has raised $400K; the latest was Later Stage VC in Feb 2025.
- Notable investors include Bangalore Bioinnovation Centre, Centre for Cellular And Molecular Platforms, Digilife, Foundation for Science Innovation and Development, Global Incubation Services — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for SIAMAF Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for SIAMAF Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SIAMAF Healthcare
Developer of magnetic nanotechnology intended for radiation-free and affordable cancer diagnosis. The company specializes in bringing advanced magnetic nanotechnology devices for cancer staging, screening, localization, imaging, hyperthermia, and removing the need for radioactivity and strong chemicals for cancer treatment, enabling healthcare providers to deliver precise, affordable and less invasive care to cancer patients.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2016
- Employees
- 9
- Website
- siamaf.com/
- Ownership
- Privately Held (backing)
SIAMAF Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SIAMAF Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SIAMAF Healthcare in its N-PORT filings yet. We sweep new filings monthly.